Patent details

Basic Information

Publication number:

EP3093290

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161637186

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MORPHINAN COMPOUNDS

French Title of Invention:

COMPOSÉS DE MORPHINANE

German Title of Invention:

MORPHINANVERBINDUNGEN

SPC Number:

Dates

Filing date:

30/04/2008

Grant date:

24/01/2018

EP Publication Date:

16/11/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/01/2018

EP B1 Publication Date:

24/01/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/04/2018

Expiration date:

30/04/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/01/2018

 

 

Name:

Concert Pharmaceuticals Inc.

Address:

99 Hayden Avenue, Suite 500, Lexington, MA 02421, United States (US)

Inventor

Name:

TUNG, Roger

Address:

United States (US)

Priority

1

Priority Number:

915130 P

Priority Date:

01/05/2007

Priority Country:

United States (US)

2

Priority Number:

916662 P

Priority Date:

08/05/2007

Priority Country:

United States (US)

3

Priority Number:

976044 P

Priority Date:

28/09/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/439; A61P 11/14; C07B 59/00; C07D 471/08;

Publication

European Patent Bulletin

Issue number:

201804

Publication date:

24/01/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/08/2018	Outgoing Correspondence	1